Ikarian Capital, LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Ikarian Capital, LLC disclosed 122 US equity positions worth $350.2m in its Q4 2024 13F filing. The largest position was TARS at 9.6% of the reported book, followed by CRNXGBP and SRRK. Against the Q3 2024 filing, it opened 17 new positions, added to 12 and reduced 15 among the top 50 holdings.
What did Ikarian Capital, LLC own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 9.6% | $33.6m | 607,689 | -41% | reduced |
| 2 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 7.5% | $26.4m | 516,431 | 21% | added | |
| 3 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 4.4% | $15.4m | 357,185 | – | new |
| 4 | 2655787D BLUEPRINT MEDICINES CORP | 4.2% | $14.8m | 169,374 | 99% | added | |
| 5 | FBRX FORTE BIOSCIENCES INC | 4.0% | $13.8m | 609,225 | – | new | |
| 6 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 2.6% | $9.0m | 469,949 | -6% | reduced |
| 7 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 2.5% | $8.9m | 394,538 | -21% | reduced |
| 8 | TGTX TG THERAPEUTICS INC | Healthcare | 2.5% | $8.8m | 291,240 | – | new |
| 9 | INSM INSMED INC | Healthcare | 2.4% | $8.3m | 119,800 | -23% | reduced |
| 10 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 2.2% | $7.7m | 284,085 | 147% | added |
| 11 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2.2% | $7.5m | 178,989 | -0% | held |
| 12 | CATALYST PHARMACEUTICALS INC | 2.1% | $7.3m | 349,649 | -16% | reduced | |
| 13 | AVTX AVALO THERAPEUTICS INC | Healthcare | 2.1% | $7.2m | 970,259 | -0% | held |
| 14 | CYTK CYTOKINETICS INC | Healthcare | 2.0% | $7.1m | 149,982 | -12% | reduced |
| 15 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.9% | $6.6m | 897,862 | – | new |
| 16 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 1.9% | $6.6m | 142,328 | -47% | reduced |
| 17 | SYRE SPYRE THERAPEUTICS INC | 1.9% | $6.6m | 282,159 | -7% | reduced | |
| 18 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.7% | $5.9m | 215,713 | -24% | reduced |
| 19 | KOD KODIAK SCIENCES INC | Healthcare | 1.6% | $5.7m | 576,166 | 21% | added |
| 20 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 1.6% | $5.6m | 378,363 | -49% | reduced |
| 21 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 1.6% | $5.5m | 152,211 | – | new |
| 22 | ELDN ELEDON PHARMACEUTICALS INC | 1.3% | $4.6m | 1,126,637 | – | new | |
| 23 | ALPHA COGNITION INC | 1.3% | $4.5m | 755,867 | – | new | |
| 24 | LENZ LENZ THERAPEUTICS INC | Healthcare | 1.2% | $4.3m | 149,502 | -27% | reduced |
| 25 | RZLT REZOLUTE INC | 1.2% | $4.2m | 857,230 | -3% | reduced | |
| 26 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 1.2% | $4.1m | 34,087 | -37% | reduced |
| 27 | EOLS EVOLUS INC | Healthcare | 1.2% | $4.1m | 373,265 | 45% | added |
| 28 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.2% | $4.1m | 332,390 | 85% | added |
| 29 | NUVALENT INC | 1.2% | $4.1m | 52,216 | -0% | held | |
| 30 | JANX JANUX THERAPEUTICS INC | Healthcare | 1.1% | $4.0m | 74,691 | – | new |
| 31 | VRNA VERONA PHARMA PLC | 1.1% | $3.7m | 80,000 | – | new | |
| 32 | HELP CYBIN INC | 1.0% | $3.5m | 397,175 | 8% | added | |
| 33 | ARCT ARCTURUS THERAPEUTICS HLDGS | Healthcare | 1.0% | $3.4m | 200,000 | – | new |
| 34 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.9% | $3.3m | 499,301 | 94% | added |
| 35 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 0.8% | $3.0m | 533,581 | -9% | reduced |
| 36 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.8% | $2.9m | 693,308 | -0% | held |
| 37 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.8% | $2.8m | 221,911 | 13% | added |
| 38 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.8% | $2.7m | 70,000 | – | new |
| 39 | ALGS ALIGOS THERAPEUTICS INC | 0.7% | $2.6m | 64,300 | – | new | |
| 40 | ZVRA ZEVRA THERAPEUTICS INC | 0.7% | $2.4m | 292,772 | – | new | |
| 41 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.7% | $2.4m | 62,052 | -42% | reduced |
| 42 | VTYXUSD VENTYX BIOSCIENCES INC | 0.7% | $2.4m | 1,092,590 | 467% | added | |
| 43 | OKUR ONKURE THERAPEUTICS INC | 0.6% | $2.2m | 253,754 | – | new | |
| 44 | GLUE MONTE ROSA THERAPEUTICS INC | 0.6% | $2.2m | 311,575 | -0% | held | |
| 45 | ACELYRIN INC | 0.6% | $2.1m | 676,608 | -0% | held | |
| 46 | CRDF CARDIFF ONCOLOGY INC | 0.6% | $2.0m | 450,000 | – | new | |
| 47 | SGMOQ SANGAMO THERAPEUTICS INC | Healthcare | 0.5% | $1.9m | 1,860,179 | – | new |
| 48 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.5% | $1.9m | 2,029,028 | 55% | added |
| 49 | TARA PROTARA THERAPEUTICS INC | 0.5% | $1.9m | 350,489 | 125% | added | |
| 50 | ALEC ALECTOR INC | Healthcare | 0.5% | $1.8m | 950,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.